Contineum Therapeutics In...
12.89
0.12 (0.94%)
At close: Jan 15, 2025, 3:59 PM
12.96
0.54%
After-hours Jan 15, 2025, 04:00 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21
PE Ratio 11.30 -15.96 -8.85
PS Ratio 5.14 n/a n/a
PB Ratio -3.78 -4.15 -3.62
P/FCF Ratio 13.56 -19.12 -9.71
P/OCF Ratio 13.27 -19.23 -9.78
OCF/S Ratio 0.39 n/a n/a
Debt / Equity Ratio -2.84 -1.48 -0.07
Quick Ratio 23.29 6.41 18.99
Current Ratio 23.29 6.41 18.99
Asset Turnover 0.38 n/a n/a
Interest Coverage 77.29 -58.56 -86.29
Return on Equity (ROE) -0.33 0.26 0.41
Return on Assets (ROA) 0.17 -0.48 -0.41
Return on Capital (ROIC) 0.13 -0.53 -0.43
Dividend Yield n/a n/a n/a
Payout Ratio n/a n/a n/a
Gross Profit Margin 100.00% n/a n/a
Net Profit Margin 45.44% n/a n/a
Pretax Profit Margin 46.34% n/a n/a
Operating Profit Margin 32.15% n/a n/a
FCF Margin 37.87% n/a n/a
EBITDA Margin 47.15% n/a n/a